Q517--Pharmacy Compounding Contingency Solicitation for Portland VA Medical Center

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 is seeking a pharmacy compounding services contract for the Portland VA Medical Center under solicitation 36C26025Q0566. The procurement focuses on pharmaceutical preparation manufacturing, specifically pharmacy services related to chemotherapy agent preparation and handling. Contractors will need to demonstrate specialized capabilities in pharmaceutical compounding, with particular expertise in managing complex chemotherapy treatment protocols. The solicitation requires detailed technical capabilities, compliance with medical safety standards, and demonstrated experience in healthcare pharmaceutical services. Interested vendors must submit their comprehensive proposals by June 12, 2025, with careful attention to the technical specifications outlined in the attached government files, including the detailed Chemotherapy Agent List.

This solicitation is not designated with any specific set-aside status, indicating open competition among qualified pharmaceutical service providers. The contract appears to be focused on the Portland VA Medical Center's specific pharmaceutical compounding needs, potentially involving ongoing chemotherapy agent preparation and distribution services. While specific award values are not explicitly detailed in the provided documentation, the procurement is categorized under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC code Q517 for Pharmacy Services. The place of performance will be the Portland VA Medical Center, suggesting a localized service requirement. Potential contractors should carefully review the attached documents, particularly the S02 36C26025Q0566.docx and 36C26025Q0566_1.docx files, to understand the full scope of requirements and technical specifications for this pharmaceutical service contract.